Biohaven (NYSE: BHVN) adds $350.0 million at-the-market share program
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Biohaven Ltd. entered into Amendment No. 2 to its Equity Distribution Agreement with J.P. Morgan Securities LLC, establishing an “at-the-market” equity offering program. From May 4, 2026, the company may sell up to an aggregate offering price of $350.0 million in common shares through J.P. Morgan as manager.
Shares may be sold on the New York Stock Exchange or via other negotiated transactions at prevailing market prices, with actual sales determined over time by the company’s capital needs and market conditions. The program is issued under an effective shelf registration statement and related base prospectus and prospectus supplement filed on May 4, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
ATM program size: $350.0 million aggregate offering price
Registration statement file number: File No. 333-295531
Equity Distribution Agreement amendment date: May 4, 2026
3 metrics
ATM program size
$350.0 million aggregate offering price
Common shares under Equity Distribution Agreement from May 4, 2026
Registration statement file number
File No. 333-295531
Shelf registration statement filed May 4, 2026
Equity Distribution Agreement amendment date
May 4, 2026
Amendment No. 2 with J.P. Morgan Securities LLC
Key Terms
Equity Distribution Agreement, at-the-market, shelf registration statement, prospectus supplement, +2 more
6 terms
Equity Distribution Agreement financial
"entered into Amendment No. 2 (“Amendment No. 2”) to the Equity Distribution Agreement, dated October 2, 2023"
An equity distribution agreement is a formal plan between a company and financial institutions to sell newly issued shares of the company's stock to investors over a period of time. It helps the company raise money gradually, similar to filling a container with water in stages, rather than all at once. For investors, it provides an organized way to buy shares and can influence the stock's supply and price.
at-the-market financial
"in an “at-the-market” equity offering program through the Manager"
"At-the-market" is a method for companies to sell new shares of stock directly into the open market over time, rather than all at once. It allows companies to raise money gradually, similar to selling slices of a pie instead of the entire pie at once, which can help manage the sale's impact on the stock price. This approach gives investors a steady supply of shares while providing companies with flexible funding options.
shelf registration statement regulatory
"offered and sold pursuant to an effective shelf registration statement (the “Registration Statement”)"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
prospectus supplement regulatory
"and a prospectus supplement, dated May 4, 2026, filed with the Securities and Exchange Commission"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
indemnification rights financial
"The Equity Distribution Agreement contains customary representations, warranties and agreements of the Company, conditions to closing, indemnification rights and obligations"
Inline XBRL technical
"104 | The cover page of this on formatted as Inline XBRL."
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
Offering Details
ATM
Offering
Offering Type
ATM
FAQ
What did Biohaven (BHVN) announce in this 8-K filing?
Biohaven entered into Amendment No. 2 to its Equity Distribution Agreement with J.P. Morgan Securities LLC, creating an at-the-market program to sell up to $350.0 million of common shares under an effective shelf registration statement and related prospectus documents.
How large is Biohaven’s new at-the-market offering program?
The at-the-market program allows Biohaven to sell common shares with an aggregate offering price of up to $350.0 million. These shares may be issued over time, giving the company flexibility to access equity capital as conditions and funding needs evolve.
Under what regulatory framework is Biohaven’s $350.0 million program issued?
The $350.0 million aggregate offering price of common shares will be offered and sold under an effective shelf registration statement filed on May 4, 2026, together with a base prospectus and a prospectus supplement filed pursuant to Rule 424(b) under the Securities Act of 1933.
Who is managing Biohaven’s at-the-market equity offering?
J.P. Morgan Securities LLC is acting as the manager under the Equity Distribution Agreement. It will facilitate sales of Biohaven’s common shares in the at-the-market program using exchange trades, negotiated transactions, or other agreed methods, subject to customary conditions and provisions.